ProVerum
Ireland-based developer of the ProVee System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH)
Dublin, Irelandwww.proverummedical.com ↗
Total raised
€69M
€68,798,444
Funding rounds
1
Investors
7
distinct backers
Active since
2025-08
latest 2025-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood53
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-08-25 | Series B | €69M | Atlantic Bridge,Enterprise Ireland,Gilde Healthcare Partners,Ireland Strategic Investment Fund (ISIF),Lightstone Ventures,MVM Partners+1 more | View deal → |
Investors
7Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Wayflyer€2.1BIreland · E-commerce
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Oura Health€779MFinland · Healthtech